Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
If you’ve thought about losing weight lately, you’re not alone. And you’re far from the first guy to look up the best weight ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
Postpartum weight loss can feel impossible at times, especially if the weight isn’t coming off as quickly as you expected.
"Platforms often promote misinformation or oversimplified solutions," one expert told Newsweek about the findings.
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...
We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
The veteran journalist, who celebrates his 65th birthday this week, first shared his weight loss secret back in 2021 when he ...